BMS halted the study earlier this year following three patient deaths in a competitor’s trial.

Nine biopharma and biotech companies named new chief financial officers this fall, strengthening finance leadership more ...

Accounting leaders from Biogen, Vertex, Akebia and Roivant share how AI boosts efficiency while human review remains ...

AstraZeneca has teamed up with Oracle to examine how AI and real-world data can be used to find potential participants for ...

New York-based Pathos AI has secured $237 million in Series E financing at a post-money valuation of approximately $3 billion ...

Molecular testing firm Qiagen has agreed to a $52.22-per-share all-cash acquisition by EQT Private Equity.

Racura is pursuing one of cancer’s most elusive targets, pairing a distinctive MYC-inhibition approach with a data-first path ...

BioXconomy highlights leading Black innovators and leaders in the biotechnology industry.

Gilead Sciences has agreed to acquire an oral IL-23R inhibitor program, led by HCXT-2001, from privately held PepStar ...

Zymeworks entered into a global licensing and collaboration agreement with Roche for ZW209, a trispecific T-cell engager ...

Earlier this week, Eli Lilly announced it broke ground on a large site in Houston, Texas. The location will be one of ten US ...

METiS TechBio has teamed up with Lilly in a deal worth $1.1bn, pairing AI-driven lipid design with pharma expertise to ...